⌘K
Loading ticker…
As of 2026-08-21, Vera Therapeutics, Inc. Class A Common Stock (VERA) has a 3-month relative strength percentile of 35 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.4%, relative volume 0.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
VERA is held by 20 ETFs as of May 2026. Top owner: VTWO at 0.06% weight, $11M notional. Top 3 carry $26M.
Held by 50 ETFs · $341M across latest filings · largest weight 1.61% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.06% | $11M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.05% | $11M | −0.01 pp |
| VHTVanguard Health Care ETF | 0.02% | $4M | — |
| SBIO | 1.61% | $3M | −0.07 pp |
| VTWG | 0.12% | $2M | −0.02 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $1M | — |
| ESML | 0.04% | $948K | −0.02 pp |
| VFMO | 0.05% | $897K | −0.02 pp |
| ONEQ | 0.01% | $674K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $189K | — |
Showing 10 of 20 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VERA Jan avg: 13.55% median: -13.21% win: 25% σ: 84.63% n: 4 2022-04-12 → 2026-07-31 | VERA Feb avg: -2.13% median: -9.05% win: 25% σ: 21.70% n: 4 2022-04-12 → 2026-07-31 | VERA Mar avg: -6.27% median: -4.89% win: 25% σ: 10.41% n: 4 2022-04-12 → 2026-07-31 | VERA Apr avg: -10.00% median: -11.48% win: 0% σ: 4.64% n: 5 2022-04-12 → 2026-07-31 | VERA May avg: -4.95% median: -3.85% win: 20% σ: 20.30% n: 5 2022-04-12 → 2026-07-31 | VERA Jun avg: 25.24% median: 20.80% win: 60% σ: 40.02% n: 5 2022-04-12 → 2026-07-31 | VERA Jul avg: 1.57% median: 1.13% win: 60% σ: 21.00% n: 5 2022-04-12 → 2026-07-31 | VERA Aug avg: 6.92% median: 3.72% win: 75% σ: 13.47% n: 4 2022-04-12 → 2026-07-31 (current) | VERA Sep avg: 6.68% median: 7.47% win: 50% σ: 24.44% n: 4 2022-04-12 → 2026-07-31 | VERA Oct avg: -11.81% median: -10.59% win: 0% σ: 9.20% n: 4 2022-04-12 → 2026-07-31 | VERA Nov avg: 15.36% median: 20.90% win: 75% σ: 17.81% n: 4 2022-04-12 → 2026-07-31 | VERA Dec avg: 16.11% median: 14.69% win: 75% σ: 26.62% n: 4 2022-04-12 → 2026-07-31 |